Tutorial
RH CHAIN
…
Wallet
Overview
Follow the Money
Daily Brief
Live
Congress
Corporate Insiders
Government Money
Political Influence
Institutions
Washington Network
Follow the Power
Disclosure Clock
AI Investigator
Watchlist
Convergence
INSIDER Alpha
Signal ledger
Historical Replay
Robinhood Chain
Proof
Trading
Token
Pro
Account
Methodology
Match review
Launch readiness
Tutorial
01
Overview
02
Follow the Money
03
Daily Brief
04
Live
05
Congress
06
Corporate Insiders
07
Government Money
08
Political Influence
09
Institutions
10
Washington Network
11
Follow the Power
12
Disclosure Clock
13
AI Investigator
14
Watchlist
Convergence
INSIDER Alpha
Signal ledger
Historical Replay
Robinhood Chain
Proof
Trading
Token
Pro
Account
Methodology
Match review
Launch readiness
Overview
Follow the Money
Daily Brief
Live
Congress
Corporate Insiders
Government Money
Political Influence
Institutions
Washington Network
Follow the Power
Disclosure Clock
AI Investigator
Watchlist
Convergence
INSIDER Alpha
Signal ledger
Historical Replay
Robinhood Chain
Proof
Trading
Token
Pro
Account
Methodology
Match review
Launch readiness
Tutorial
Data sources
SEC FORM 4
28m ago
HOUSE PTR
27m ago
SEC 13F
27m ago
ROBINHOOD CHAIN
27m ago
Public company
LPCN
Lipocine Inc.
CIK 0001535955
EDGAR filings
Open in network
○
Watch LPCN
Disclosed transactions
1
Buys / sells
1 / 0
Max Insider Score
33
Connections
2
with evidence
LPCN · disclosed activity on price
Disclosed transactions
Score
Actor
Security
Side
Value
Executed
Disclosed
Lag
Source
Evidence
33
HW
Higuchi John W.
Director
LPCN
Lipocine Inc.
Open-market purchase
BUY
$27K
12.6K sh
Sep 28, 2026
Sep 30, 2026
traded Sep 28, 2026
+2d
SEC FORM 4
Evidence
Evidence
Close
Verified connections
In industry
evidence
Pharmaceuticals, devices & health services
SEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
← Insider of
evidence
Higuchi John W.
Director · Sep 30, 2026